Abstract

Type II mast cells in mast cell leukemia: Uncommon yet clinically significant.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V
Karoline V Gleixner ... Barbara Peter
Experimental Hematology | VOL. 38
Karoline V Gleixner, et. al.Karoline V Gleixner ... Barbara Peter
27 May 2010
Identification of a Neoplastic Stem Cell in Human Mast Cell Leukemia
Wolfgang R Sperr ... Thomas Rülicke
Blood | VOL. 124
Wolfgang R Sperr, et. al.Wolfgang R Sperr ... Thomas Rülicke
06 Dec 2014
Reappraisal of Mast Cell Leukemia Based on a Single Institution Review of 16 Cases: Role of Mast Cell Morphology in Determining Clinical Outcome
Ayalew Tefferi ... Aref Al-Kali
Blood | VOL. 140
Ayalew Tefferi, et. al.Ayalew Tefferi ... Aref Al-Kali
15 Nov 2022
Treatment of Patients with Aggressive Systemic Mastocytosis, Mast Cell Leukemia and Mast Cell Sarcoma: A Single Center Experience
Peter Valent ... Karoline V Gleixner
Blood | VOL. 132
Peter Valent, et. al.Peter Valent ... Karoline V Gleixner
29 Nov 2018
View more papers

More From: EJHaem

Paper Title
Journal
Date
Author
Development of the treatment preference in myelodysplasia questionnaire for clinicians, carers, and patients
Robert Morlock ... Anoop Enjeti
eJHaem | VOL. -
Robert Morlock, et. al.Robert Morlock ... Anoop Enjeti
28 May 2024
Alpha globin gene alterations modifying the phenotype of homozygous beta thalassaemia
Jyoti Shaw ... Maitreyee Bhattacharyya
eJHaem | VOL. -
Jyoti Shaw, et. al.Jyoti Shaw ... Maitreyee Bhattacharyya
27 May 2024
Correction to “Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis”
-
eJHaem | VOL. -
--
24 May 2024
Coinheritance of non‐deletional hemoglobin H disease with sickle cell trait
Veroniki Komninaka ... Evangelia‐Eleni Ntelaki
eJHaem | VOL. -
Veroniki Komninaka, et. al.Veroniki Komninaka ... Evangelia‐Eleni Ntelaki
24 May 2024
View more papers